The Claim
Matrix Gla protein is present in an inactive, undercarboxylated form at sites of vascular calcification and neointimal hyperplasia in human arterialized veins, indicating local vitamin K deficiency in the vessel wall.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In human arterialized veins with vascular calcification and neointimal hyperplasia, Matrix Gla protein is found in an inactive form, which reflects a local deficiency of vitamin K in the vessel wall.
See the scientific wording
Matrix Gla protein is present in an inactive, undercarboxylated form at sites of vascular calcification and neointimal hyperplasia in human arterialized veins, indicating local vitamin K deficiency in the vessel wall.
When there is not enough vitamin K in the vessel wall, a protein called matrix Gla protein cannot be activated. This inactive protein cannot stop calcium from building up in the blood vessel walls. The calcium deposits trigger cells in the vessel wall to change and multiply abnormally, causing thickening and hardening of the vessel. This process happens exactly where calcium builds up and tissue grows too much.
What the research says
1 studyIn dialysis patients, the study found that a protective protein in blood vessels was broken and inactive right where calcium built up and tissue grew abnormally — and giving vitamin K fixed the protein, suggesting the tissue was just missing enough vitamin K.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.